SUBSCRIBE
SUBSCRIBE
News   Business

Repros Therapeutics Inc. Reports Third Quarter 2010 Financial Results and Provides Corporate Update

November 10, 2010 | 
1 min read
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc.® (NasdaqCM: RPRXD) today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.
Earnings
MORE ON THIS TOPIC
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie